WeVote
Log In

Bill

Bill

A 9140

Provides liability protections for health care providers who issue vaccines

2025 Regular Session Introduced by Linda Rosenthal

Provides civil liability protections for health care providers who administer vaccines in good faith and per guidelines, to support vaccine access.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 9140

Summary of Bill A 9140: Provides Liability Protections for Health Care Providers Who Issue Vaccines

Overview

Bill A 9140 proposes liability protections for health care providers who administer vaccines. The bill is currently in the Health committee stage, having been introduced on October 17, 2025, and referred to the Health committee on that same date. The primary sponsor listed is Linda Rosenthal.

Purpose and Intent

  • To reduce civil liability risk for health care providers when issuing vaccines, with the aim of supporting vaccination effort and access.
  • To encourage clinicians and facilities to offer vaccines without the fear of civil lawsuits stemming from vaccine administration, provided steps and standards are followed.

Key Provisions (based on the bill’s title and typical structure)

Note: The full text of A 9140 is not provided here, so the following reflects expected elements commonly found in liability-protection measures for vaccination programs. The exact language may differ in the official bill.

  • Liability protection: Establishes civil liability protections for health care providers who administer vaccines in good faith and in compliance with applicable guidelines and standards of care.
  • Scope of protection: Likely limited to vaccines administered in accordance with state and federal guidelines (and potentially state-imposed vaccination programs).
  • Exclusions from protection: Typically excludes protections in cases of willful misconduct, gross negligence, fraud, misrepresentation, or noncompliance with mandatory storage, handling, or administration requirements.
  • Conditions for eligibility: Providers must adhere to established professional standards, obtain informed consent, and maintain appropriate records for vaccine administration and adverse event reporting.
  • Adverse events and reporting: May require standardized reporting of adverse events to relevant authorities; protections could be contingent on timely and accurate reporting.
  • Relationship to existing law: May clarify interaction with federal immunization programs and other existing liability frameworks.

Affected Parties

  • Health care providers that administer vaccines (physicians, nurses, pharmacists, clinics, hospitals, and other eligible facilities).
  • Patients receiving vaccines may indirectly benefit through streamlined access and potentially quicker resolution of vaccination-delivery concerns.
  • Health care institutions and systems with vaccination programs.

Procedural and Timeline Aspects

  • Introduced: October 17, 2025.
  • Status: Referred to Health committee (listed twice in the action notes, both on October 17, 2025).
  • Next steps: Committee hearings, potential amendments, and eventual floor votes; timeline to enactment will depend on committee action and legislative calendar.

Sponsor

  • Primary sponsor: Linda Rosenthal.

Potential Impacts and Considerations

  • Public health impact: Could facilitate broader vaccine access by reducing provider liability concerns.
  • Patient protections: Depending on text, protections may be balanced with ongoing accountability for negligent care or violations of consent and reporting requirements.
  • Legal and financial: May affect malpractice risk calculus, insurance coverage, and cost for health care entities, with potential budgetary implications if new protections intersect with compensation frameworks for vaccine injuries.

Note: This summary reflects the bill’s title and status. The exact provisions, amendments, and final scope will be stated in the official bill text published by the legislature.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.